Article | October 16, 2023

Delivering On-Time, Every Time: 4 Key Factors For Evaluating A CDMO To Improve Timelines

By Cory Lewis, Chief Executive Officer and President, INCOG BioPharma Services

Vials pharma manufacturing GettyImages-618518692

Meeting delivery timelines is a critical requirement for biopharma companies bringing a product to market. Receiving the drug “on time, every time” from an outsourcing partner is a challenging factor, according to customer surveys published in the “CDMO Outsourcing Models Edition” by ISR Reports.

Dealing with the inevitable challenges that arise from complex sterile injectable manufacturing operations is crucial for biopharma companies to meet their expectations of delivery timelines. Sponsors must evaluate a CDMO to ensure that an experienced, knowledgeable team is in place and their facility is equipped with flexible manufacturing systems. Review four key factors for improving on-time delivery when outsourcing drug product manufacturing and discover how investing in building a solid relationship with your CDMO will help improve timelines.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma